Regimens of factor VIII administration--continuous infusion vs. bolus
(2000) In Haematologica 85(10 Suppl). p.69-69- Abstract
- The Malmo protocol for immune tolerance induction uses intermittent injections of factor VIII/IX together with intravenous IgG and cyclophosphamide. In order to increase the production of antigen-antibody complexes, and also to improve cost-efficacy, we applied continuous infusion instead of intermittent injection in 5 high-responders (3 hemophilia A and 2 hemophilia B). All treatment attempts failed. However, we conclude that continuous infusion may play a role in immune tolerance induction, and the treatment failures in our study could probably be explained by the fact that the patients were partially selected to be resistant cases.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1117532
- author
- Berntorp, Erik LU
- organization
- publishing date
- 2000
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Haematologica
- volume
- 85
- issue
- 10 Suppl
- pages
- 69 - 69
- publisher
- Ferrata Storti Foundation
- external identifiers
-
- pmid:11187875
- scopus:0033710126
- ISSN
- 1592-8721
- language
- English
- LU publication?
- yes
- id
- 6b42d2c4-3aab-4226-a496-6af858e7cf11 (old id 1117532)
- date added to LUP
- 2016-04-01 16:35:40
- date last changed
- 2022-01-28 20:45:00
@article{6b42d2c4-3aab-4226-a496-6af858e7cf11, abstract = {{The Malmo protocol for immune tolerance induction uses intermittent injections of factor VIII/IX together with intravenous IgG and cyclophosphamide. In order to increase the production of antigen-antibody complexes, and also to improve cost-efficacy, we applied continuous infusion instead of intermittent injection in 5 high-responders (3 hemophilia A and 2 hemophilia B). All treatment attempts failed. However, we conclude that continuous infusion may play a role in immune tolerance induction, and the treatment failures in our study could probably be explained by the fact that the patients were partially selected to be resistant cases.}}, author = {{Berntorp, Erik}}, issn = {{1592-8721}}, language = {{eng}}, number = {{10 Suppl}}, pages = {{69--69}}, publisher = {{Ferrata Storti Foundation}}, series = {{Haematologica}}, title = {{Regimens of factor VIII administration--continuous infusion vs. bolus}}, volume = {{85}}, year = {{2000}}, }